Tongxinluo Decreases Apoptosis of Mesenchymal Stem Cells Concentration-dependently Under Hypoxia and Serum Deprivation Conditions Through the AMPK/eNOS Pathway-Reference-Cited by-同舟云学术

Tongxinluo Decreases Apoptosis of Mesenchymal Stem Cells Concentration-dependently Under Hypoxia and Serum Deprivation Conditions Through the AMPK/eNOS Pathway

Published:2014-03 Issue:3 Volume:63 Page:265-273
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Li Na,Yang Yue-Jin,Cui He-He,Zhang Qian,Jin Chen,Qian Hai-Yan,Dong Qiu-Ting,Zhang Hao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference38 articles.

1. Mesenchymal stem cells and cardiac repair

2. Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart

3. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells

4. Chinese medicine tongxinluo significantly lowers serum lipid levels and stabilizes vulnerable plaques in a rabbit model

5. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications;Phytomedicine;2024-09

2. Clinical effects and mechanisms of a Chinese patent medicine, Tongxinluo capsule, as an adjuvant treatment in coronary heart disease;Heliyon;2024-03

3. Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction;Frontiers in Pharmacology;2022-10-18

4. Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1/NF-κB p65 pathway;Stem Cell Research & Therapy;2022-07-07

5. Ginsenoside Rh2 Inhibits NLRP3 Inflammasome Activation and Improves Exosomes to Alleviate Hypoxia-Induced Myocardial Injury;Frontiers in Immunology;2022-07-05